embraca: results of talazoparib vs chemotherapy relative to prior ct in patients with advanced b...
Published 5 years ago • 143 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
4:10
the embraca trial for advanced breast cancer, a new parp inhibitor
-
2:07
parp inhibitors and the embraca study of talazoparib in brca-related metastatic breast cancer
-
3:52
the phase 3 embraca study of talazoparib in brca-related metastatic breast cancer
-
4:51
telazoparib vs physicians choice for patients with mbrca1 breast cancer
-
6:18
talazoparib in patients with advanced breast cancer and germline brca mutation
-
4:41
a variety of approaches to measure the efficacy of parp inhibitors
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
1:41
parp inhibitors are a promising alternative to chemotherapy for patients with metastatic brca1 a...
-
3:04
advances in parp inhibitor use for metastatic breast cancer
-
2:21
a study of talazoparib in somatic brca1/2 mutant mbc identified by cfdna or tumor tissue genotyping
-
3:27
tripathy discusses a study of talazoparib in brca-mutated advanced breast cancer
-
0:58
dr. litton on the embraca trial in advanced brca1/2 breast cancer
-
2:59
parp inhibitors for metastatic breast cancer
-
2:02
dr. litton on a study of neoadjuvant talazoparib for patients with brca-mutated tnbc
-
4:56
neoadjuvant talazoparib active in brca-mutated early breast cancer | jennifer litton
-
5:52
talapro-1: phase ii study of talazoparib in patients with dna damage repair alterations and mcrpc
-
9:32
brca mutation in metastatic tnbc patients
-
1:58
dr. joanne blum on the embraca trial in metastatic brca-mutant breast cancer